Putting nature back into drug discovery
- 1 June 2003
- journal article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 21 (6), 602
- https://doi.org/10.1038/nbt0603-602
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Natural Products Are Biologically Validated Starting Points in Structural Space for Compound Library Development: Solid-Phase Synthesis of Dysidiolide-Derived Phosphatase Inhibitors This research was supported by the Fonds der Chemischen Industrie and the Bayer AG.Angewandte Chemie-International Edition, 2002
- Pure compound libraries; a new perspective for natural product based drug discoveryDrug Discovery Today, 2001
- Is There a Difference between Leads and Drugs? A Historical PerspectiveJournal of Chemical Information and Computer Sciences, 2001
- Scaffold Architecture and Pharmacophoric Properties of Natural Products and Trade Drugs: Application in the Design of Natural Product-Based Combinatorial LibrariesJournal of Combinatorial Chemistry, 2001
- Strategies for discovering drugs from previously unexplored natural productsDrug Discovery Today, 2000
- Statistical Investigation into the Structural Complementarity of Natural Products and Synthetic CompoundsAngewandte Chemie-International Edition, 1999
- Stereoselective Synthesis of over Two Million Compounds Having Structural Features Both Reminiscent of Natural Products and Compatible with Miniaturized Cell-Based AssaysJournal of the American Chemical Society, 1998
- Synthesis of epothilones A and B in solid and solution phaseNature, 1997
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- Natural Products in Drug Discovery and DevelopmentJournal of Natural Products, 1997